PitchSend

Investor Presentaiton

Financial Highlights Revenue (In Rs. Crs.) 856 760 +17% 998 1,228 Normalized EBITDA (In Rs. Crs.) 232 207 362 +20% 301 METROPOLIS The Pathology Specialist Normalized EBITDA (%) 30.2% 29.4% 27.3% 27.3% FY19 FY20 FY21 FY22 FY19 FY20 FY21 FY22 FY19 FY20 FY21 FY22 Reported PAT (In Rs. Crs.) 124 128 +20.2% ROCE (%)* 215 43.1% 38.5% 183 35.6% 26.1% ROE (%)* 29.4% 25.9% 24.3% 24.2% FY19 FY20 FY21 FY22 FY19 FY20 FY21 FY22 FY19 FY20 FY21 FY22 *ROCE EBIT / (Networth + Total Debt) ROE PAT/Networth 60 60

View entire presentation